A Study on a Digital Platform for COVID19+ Patients, Designed to Facilitate Communication and Mental-health Care During and After Hospitalization.
Launched by FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO · Feb 8, 2022
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18-80
- • 2. A positive COVID-19 test at the moment of enrolment for subjects in the 'patients' group
- • 3. Adequate sensory and motor abilities, without impairments in vision, hearing and handling devices
- • 4. Access to Internet wireless technologies.
- • 5. A good level of Italian in terms of speaking, reading and writing.
- Exclusion Criteria:
- • 1. Present of past medical history of schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder, current substance abuse, all according to the diagnostic and statistical manual fifth edition (DSM-5) (American Psychiatric Association, 2013).
- • 2. With a diagnosis of cognitive impairment and/or dementia (e.g., mild cognitive impairment, Alzheimer's disease, Parkinson's disease);
- • 3. Intellectual disability defined by a total IQ \< 70 in Test di Intelligenza Breve (TIB) (Sartori et al., 1997) or Standard Progressive Raven Matrices (John \& Raven, 2003)
- • 4. Severe present medical conditions that could interfere with participation.
- • 5. Present or past suicidal ideation or commitment.
- • 6. Significant impairment in the use of digital and technological devices, in questionnaires and test completions, comprehension or with lack of a compliant behavior in the earliest evaluations.
- • 7. Being enrolled in other clinical trials assessing any psychological, or experimental pharmacological treatment.
About Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is a prestigious research and clinical care institution based in Milan, Italy. Renowned for its commitment to advancing medical knowledge and improving patient outcomes, the foundation integrates cutting-edge research with high-quality healthcare services. It serves as a hub for innovative clinical trials, fostering collaborations among healthcare professionals, researchers, and academic institutions. With a focus on various therapeutic areas, the foundation aims to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Patients applied
Trial Officials
Paolo Brambilla
Principal Investigator
Università degli Studi di Milano, Fondazione Policlinico di Milano
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials